Suscribirse

Diagnostic Criteria for Atrophic Rhinosinusitis - 12/08/11

Doi : 10.1016/j.amjmed.2008.12.025 
Tran H. Ly, MD a, Richard D. deShazo, MD a, , Jake Olivier, PhD b, c, Scott P. Stringer, MD d, William Daley, MD e, Christopher M. Stodard, MSc f
a Division of Clinical Immunology and Allergy, Department of Medicine, University of Mississippi Medical Center, Jackson 
b NSW Injury Risk Management Research Centre, University of New South Wales, Sydney, Australia 
c School of Mathematics and Statistics, University of New South Wales, Sydney, Australia 
d Department of Otolaryngology, University of Mississippi Medical Center, Jackson 
e Department of Pathology, University of Mississippi Medical Center, Jackson 
f School of Medicine, University of Mississippi Medical Center, Jackson 

Requests for reprints should be addressed to Richard D. deShazo, MD, Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216-4505

Abstract

Background

Patients with atrophic rhinosinusitis have intractable upper airway symptoms that result from loss of the normal nasal epithelium. There is no consensus on how to diagnose this condition, and diagnostic criteria are not available to perform multicenter treatment trials. We sought to establish diagnostic criteria for atrophic rhinosinusitis.

Methods

Twenty-two patients for whom there was a consensus on the diagnosis of atrophic rhinosinusitis were compared with a control group of 22 randomly selected patients with garden-variety chronic rhinosinusitis. Medical records were reviewed on all patients and clinical data were tabulated. Clinical variables included the presence of nasal obstruction, epistaxis, anosmia, purulence, crusting, chronic inflammatory disease involving the upper airway, and multiple sinus surgeries.

Results

Both groups had similar degrees of persistent nasal obstruction (82% vs 77%). The other 6 clinical features occurred more frequently in patients with atrophic rhinosinusitis than controls (P <.05). Patients with chronic rhinosinusitis and recurrent nasal purulence had a 25-fold (95% confidence interval [CI], 2.9-221.7) increased probability, those with recurrent epistaxis had a 12-fold increased probability (95% CI, 1.3-106.8), and those with 2 or more sinus surgeries had a 15-fold (95% CI, 3.5-66.7) increased probability of having atrophic rhinosinusitis. As the number of symptoms increased, there was an increasing probability of the predetermined diagnosis of atrophic rhinosinusitis (P <.05). The presence of chronic rhinosinusitis and any 2 of the 6 clinical features for 6 months or longer resulted in a sensitivity of 0.95 and specificity of 0.77 for the diagnosis of atrophic rhinosinusitis.

Conclusion

The diagnosis of the common secondary form of atrophic rhinosinusitis may be made with certainty if a patient with chronic rhinosinusitis demonstrates 2 or more clinical features for 6 months and longer. These features are patient-reported recurrent epistaxis or episodic anosmia; or physician-documented nasal purulence, nasal crusting, chronic inflammatory disease of the upper airway, or 2 or more sinus surgeries.

El texto completo de este artículo está disponible en PDF.

Keywords : Nasal polyposis, Rhinosinusitis, Sinus surgery


Esquema


 Funding: None.
 Conflict of Interest: None.
 Authorship: The authors each had access to the data and a role in writing this manuscript.


© 2009  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 122 - N° 8

P. 747-753 - août 2009 Regresar al número
Artículo precedente Artículo precedente
  • Medical Bankruptcy in the United States, 2007: Results of a National Study
  • David U. Himmelstein, Deborah Thorne, Elizabeth Warren, Steffie Woolhandler
| Artículo siguiente Artículo siguiente
  • Raloxifene and Risk for Stroke Based on the Framingham Stroke Risk Score
  • Elizabeth Barrett-Connor, David A. Cox, Jingli Song, Bruce Mitlak, Lori Mosca, Deborah Grady

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.